infohep news

• New

  Hepatitis C virus dried on inanimate surfaces can remain infectious for up to six weeks

  Keith Alcorn / Less than 1 hour ago

  Dried spots of blood contaminated with hepatitis C virus (HCV) can remain infectious for up to six weeks at normal room temperatures, research published in the online edition of the Journal of Infectious ...

• Black hepatitis C patients do well on sofosbuvir oral regimens

  Liz Highleyman / 03 December 2013

  Interferon-free treatment using a single once-daily combination pill containing sofosbuvir plus ledipasvir demonstrated potent activity against hepatitis C virus (HCV)  and was generally well tolerated in a primarily African-American inner city population with ...

• Interferon-free regimens

  Faldaprevir all-oral regimen shows 100% response rate for people with HCV 1a in interim analysis

  Liz Highleyman / 02 December 2013

  An interferon-free regimen of faldaprevir, deleobuvir and PPI-668 led to a 4-week post-treatment sustained virological response (SVR4) in treatment-naive patients with hard-to-treat HCV subtype 1a in an ongoing phase 2 trial, according to ...

• Antiviral therapy

  Entecavir + tenofovir works well for people with hepatitis B who have had prior treatment failure

  Liz Highleyman / 28 November 2013

  A dual regimen of entecavir (Baraclude) plus tenofovir (Viread) for 48 weeks led to virological response and was generally well-tolerated among people with chronic hepatitis B who had experienced treatment failure with ...

• Interferon-free regimens

  Daclatasvir + asunaprevir cures 85% of genotype 1b hepatitis C patients in Japanese study

  Liz Highleyman / 27 November 2013

  An interferon- and ribavirin-free oral regimen of daclatasvir plus asunaprevir taken for 24 weeks led to sustained virological response (SVR12) in 85% of Japanese patients with hepatitis C virus subtype 1b, according to ...